首页>
外国专利>
Compound 1 - cyano - 3-pyrrolidinyl - benzenesulfonamide Pharmaceutical composition containing same and their use for preparing a Medicament used to treat chronic obstructive pulmonary disease (COPD)
Compound 1 - cyano - 3-pyrrolidinyl - benzenesulfonamide Pharmaceutical composition containing same and their use for preparing a Medicament used to treat chronic obstructive pulmonary disease (COPD)
Compound of 1-cyano-3-pyrrolidinyl-benzenesulfonamide which are cathepsin C inhibitors of formula (1) or (2) and a salt thereof in which n is 1--5, each R1 is independently halo; OR2, C1-10 alkyl unsubstituted or substituted with halo or an unsubstituted or substituted heteroaromatic ring containing 1-3 heteroatoms selected from the group consisting of N, O or S; CN; C (O) NR3R4, NO2, NHC (O) NR5R6, NR7R8, a heteroaromatic ring containing 1-3 heteroatoms selected from the group consisting of N, O or S; aryl, unsubstituted or substituted with halo or C1-6 alkyl, C3-6 cycloalkyl, C4-6 cycloalkenyl, C1-10 alkenyl, C1-10 alkynyl or C (O) OR2; R2 is H, C1-6 alkyl,C1-6 haloalkyl, C (O) R9; R3 is H; C1-6 alkyl; C3-6 cycloalkyl or C3-6 heterocycloalkyl containing N, O or S and in which when the ring heteroatom is N is optionally substituted with CN; R4 is H, or C1-6 alkyl; R5 and R6 are independently H; C1-6 alkyl, aryl unsubstituted or substituted with halo, C1-4 alkoxy, C1-4 alkyl, or OR2; C1-10 alkyl unsubstituted or substituted with halo or C1-4 alkoxy, C3-6 cycloalkyl, C3-6 cycloalkylalkyl, C1-10 alkenyl, C1-10 alkynyl; C3-6 heterocycloalkyl, C3-6 heterocycloalkyl-C1-6 alkyl, C1-6 heteroarylalkyl or heteroaryl in which the heteroaryl ring is not substituted or is substituted by halo,1. C1-6 tar or C1-6 tar is replaced by halogenation; or arilalquilo C1-6, where arilo is not replaced by halogenation, or 2 or C (o);R7 and R8 are independently H; C1-10 alkyl, C1-6 arylalkyl in which the aryl group is unsubstituted or substituted by R9, halo, or C1-6 alkyl; C1-10 alkyl substituted with C3-6 cycloalkyl, one or more OH groups, halo; C1-6 heteroarylalkyl, or heteroaryl; or R9 is OH, C1-6 alkyloxy or NR2'R3 ',Where r2'o R3 is an independent h or C1-6. A pharmacist who understands this It is used to produce effective drugs (COPD) for the treatment of COPD.
展开▼
机译:作为式(1)或(2)的组织蛋白酶C抑制剂的1-氰基-3-吡咯烷基-苯磺酰胺的化合物及其盐,其中n为1--5,每个R 1独立地为卤素。 OR2,未取代或被卤素取代的C1-10烷基,或含有1-3个选自N,O或S的杂原子的未取代或取代的杂芳族环; CN; C(O)NR3R4,NO2,NHC(O)NR5R6,NR7R8,杂芳环,含有1-3个选自N,O或S的杂原子;未取代或被卤素或C 1-6烷基,C 3-6环烷基,C 4-6环烯基,C 1-10烯基,C 1-10炔基或C(O)OR 2取代的芳基; R2是H,C1-6烷基,C1-6卤代烷基,C(O)R9; R3为H; C 1-6烷基;含有N,O或S的C 3-6环烷基或C 3-6杂环烷基,其中当环杂原子为N时,其任选地被CN取代; R4是H或C1-6烷基; R5和R6独立地为H; C 1-6烷基,未被取代或被卤素,C 1-4烷氧基,C 1-4烷基或OR 2取代的芳基;未被取代或被卤素或C1-4烷氧基,C3-6环烷基,C3-6环烷基烷基,C1-10烯基,C1-10炔基取代的C1-10烷基; C 3-6杂环烷基,C 3-6杂环烷基-C 1-6烷基,C 1-6杂芳基烷基或杂芳基环未被取代或被卤素取代的杂芳基,1。 C1-6焦油或C1-6焦油被卤化取代;或alilalquilo C1-6,其中arilo不被卤代取代,或2或C(o); R7和R8独立为H;或C 1-10烷基,C 1-6芳烷基,其中芳基未被取代或被R 9,卤素或C 1-6烷基取代; C1-10被C3-6环烷基取代的烷基,一个或多个OH基,卤素; C 1-6杂芳基烷基或杂芳基;或R 9是OH,C 1-6烷氧基或NR 2'R 3',其中r 2'o R 3是独立的h或C 1-6。了解这一点的药剂师用于生产治疗COPD的有效药物(COPD)。
展开▼